Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease

被引:170
|
作者
Mungas, D
Reed, BR
Jagust, WJ
DeCarli, C
Mack, WJ
Kramer, JH
Weiner, MW
Schuff, N
Chui, HC
机构
[1] Univ Calif Davis, Sch Med, Dept Neurol, Sacramento, CA 95817 USA
[2] Univ So Calif, Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA
[3] Univ So Calif, Sch Med, Dept Neurol, Los Angeles, CA 90089 USA
[4] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Sch Med, Dept Radiol, San Francisco, CA 94143 USA
[6] Dept Vet Affairs Med Ctr, Magnet Resonance Unit, San Francisco, CA USA
关键词
D O I
10.1212/WNL.59.6.867
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To examine volumetric MRI correlates of longitudinal cognitive decline in normal aging, AD, and 'subcortical cerebrovascular brain injury (SCVBI). Background: Previous cross-sectional studies examining the relationship between cognitive impairment and dementia have shown that hippocampal and cortical gray matter atrophy are the most important predictors of cognitive impairment, even in cases with SCVBI. The authors hypothesized that hippocampal and cortical gray matter volume also would. best predict rate of cognitive decline in cases with and without SCVBI. Methods: Subjects were recruited for a multicenter study of contributions to dementia of AD and SCVBI. The sample (n = 120) included cognitively normal, cognitively impaired, and demented cases with and without lacunes identified by MRI. Cases with cortical strokes were excluded. Average length of follow-up was 3.0 years. Measures of hippocampal volume, volume of cortical gray matter, presence of subcortical lacunes, and volume of white matter hyperintensity were derived from MRI. Random effects modeling of longitudinal data was used to assess effects of baseline MRI variables on longitudinal change in a measure of global cognitive ability. Results: Cortical gray matter atrophy predicted cognitive decline regardless of whether lacunes were present. Hippocampal atrophy predicted decline only in those without lacunes. Neither lacunes nor white matter hyperintensity independently predicted decline. Conclusions: Results suggest that cortical atrophy is an index of disease severity in both AD and subcortical cerebrovascular brain injury and consequently predicts faster progression. Hippocampal volume may index disease severity and predict progression in AD. The absence of this effect in cases with lacunes suggests that this group is etiologically heterogeneous and is not composed simply of cases of AD with incidental stroke.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 50 条
  • [21] The rate of cognitive decline in Parkinson disease
    Aarsland, D
    Andersen, K
    Larsen, JP
    Perry, R
    Wentzel-Larsen, T
    Lolk, A
    Kragh-Sorensen, P
    ARCHIVES OF NEUROLOGY, 2004, 61 (12) : 1906 - 1911
  • [22] Optical coherence tomography predicts cognitive decline in AD and MCI patients
    Santangelo, R.
    Huang, S. C.
    Falautano, M.
    Filippi, M.
    Comi, G.
    Magnani, G.
    Leocani, P. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 270 - 270
  • [23] Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease
    Kuczynski, Beth
    Reed, Bruce
    Mungas, Dan
    Weiner, Michael
    Chui, Helena C.
    Jagust, William
    ARCHIVES OF NEUROLOGY, 2008, 65 (05) : 650 - 655
  • [24] Cerebrovascular disease, Alzheimer's disease biomarkers and longitudinal cognitive decline
    Yates, P. A.
    Villemagne, V. L.
    Ames, D.
    Masters, C. L.
    Martins, R. N.
    Desmond, P.
    Burnham, S.
    Maruff, P.
    Ellis, K. A.
    Rowe, C. C.
    AUSTRALASIAN JOURNAL ON AGEING, 2016, 35 : 18 - 19
  • [25] Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease-related cognitive decline: Multi-site validation in the MarkVCID Consortium
    Liu, Peiying
    Lin, Zixuan
    Hazel, Kaisha
    Pottanat, George
    Xu, Cuimei
    Jiang, Dengrong
    Pillai, Jay J.
    Lucke, Emma
    Bauer, Christopher E.
    Gold, Brian T.
    Greenberg, Steven M.
    Helmer, Karl G.
    Jann, Kay
    Jicha, Gregory
    Kramer, Joel
    Maillard, Pauline
    Mulavelil, Rachel M.
    Rodriguez, Pavel
    Satizabal, Claudia L.
    Schwab, Kristin
    Seshadri, Sudha
    Singh, Herpreet
    Dedios, Angel G. Velarde
    Wang, Danny J. J.
    Kalyani, Rita R.
    Moghekar, Abhay
    Rosenberg, Paul B.
    Yasar, Sevil
    Albert, Marilyn
    Lu, Hanzhang
    ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5281 - 5289
  • [26] Citicoline May Prevent Cognitive Decline in Patients with Cerebrovascular Disease
    Almeria, Marta
    Alvarez, Ignacio
    Molina-Seguin, Jessica
    Besora, Sarah
    Buongiorno, Mariateresa
    Romero, Silvia
    Casas, Laura
    Cano, Cristina
    Castejon, Judith
    Arribas, Sonia
    Krupinski, Jerzy
    CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 1093 - 1102
  • [27] Electrophysiological and information processing variability predicts memory decrements associated with normal age-related cognitive decline and Alzheimer's disease (AD)
    Hogan, Michael J.
    Carolan, Leigh
    Roche, Richard A. P.
    Dockree, Paul M.
    Kaiser, Jochen
    Bunting, Brendan P.
    Robertson, Ian H.
    Lawlor, Brian A.
    BRAIN RESEARCH, 2006, 1119 : 215 - 226
  • [28] APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease
    Frikke-Schmidt, R
    Nordestgaard, BG
    Thudium, D
    Gronholdt, MLM
    Tybjærg-Hansen, A
    NEUROLOGY, 2001, 56 (02) : 194 - 200
  • [29] COGNITIVE DECLINE AND MORTALITY IN ALZHEIMERS-DISEASE (AD)
    BURNS, A
    JACOBY, R
    LEVY, R
    NEUROBIOLOGY OF AGING, 1990, 11 (03) : 258 - 258
  • [30] Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease
    Andrews, S. C.
    Langbehn, D. R.
    Craufurd, D.
    Durr, A.
    Leavitt, B. R.
    Roos, R. A.
    Tabrizi, S. J.
    Stout, J. C.
    PSYCHOLOGICAL MEDICINE, 2021, 51 (08) : 1338 - 1344